Does ROSUVASTATIN Cause Hepatic function abnormal? 213 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 213 reports of Hepatic function abnormal have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.6% of all adverse event reports for ROSUVASTATIN.
213
Reports of Hepatic function abnormal with ROSUVASTATIN
0.6%
of all ROSUVASTATIN reports
14
Deaths
88
Hospitalizations
How Dangerous Is Hepatic function abnormal From ROSUVASTATIN?
Of the 213 reports, 14 (6.6%) resulted in death, 88 (41.3%) required hospitalization, and 9 (4.2%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 213 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ROSUVASTATIN Alternatives Have Lower Hepatic function abnormal Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN